胸腺基质淋巴细胞生成素在慢性阻塞性肺疾病急性发作期患者预后评价中的应用  

The application of prognosis evaluation for TSLP in AECOPD patients

作　　者：李志波[1] 林淑媚[1] 峗淑莉[1] 

机构地区：[1]广东省中山市陈星海医院,广东中山528415

出　　处：《吉林医学》2016年第10期2408-2409,共2页Jilin Medical Journal

摘　　要：目的:探讨胸腺基质淋巴细胞生成素(TSLP)在慢性阻塞性肺疾病急性发作期(AECOPD)患者预后评价中的应用效果情况。方法:分析60例AECOPD患者和60例非AECOPD患者临床资料,分为AECOPD组和非AECOPD组。观察两组患者治疗前后Pa O2、Pa CO2、白细胞计数、PCT、CPR和TSLP。结果:AECOPD组患者治疗前Pa O2、白细胞计数均低于非AECOPD组,PCT、CPR和TSLP均高于非AECOPD组,治疗后AECOPD组TSLP高于非AECOPD组,差异有统计学意义(P<0.05)。结论:TSLP和AECOPD发展有着密切的关系,对于指导临床治疗提供了可靠的理论依据。Objective To approach application result of prognosis evaluation for TSLP in AECOPD patients. Method The clinical data of 60 cases of AECOPD patients and 60 cases of no AECOPD patients in our hospital ICU,which was to be divided into AECOPD group and no AECOPD group. The Pa O2、Pa CO2、WBC、PCT、CPR and TSLP of two groups patients were detected. Results The Pa O2、WBC of AECOPD group before treatment were lower than no AECOPD group,PCT、CPR and TSLP were higher than no AECOPD group,the TSLP of AECOPD group after treatment was higher than no AECOPD group,the difference were statistically significant（ P〈0. 05）. Conclusion The TSLP and AECOPD development are intimate relationship,which could provide reliable theoretical basis for guidancing for clinical treatment.

关 键 词：TSLP AECOPD 预后 应用 

分 类 号：R563.9[医药卫生—呼吸系统]